Herbalife Ltd. Files Q2 2024 10-Q

Ticker: HLF · Form: 10-Q · Filed: Jul 31, 2024 · CIK: 1180262

Herbalife LTD. 10-Q Filing Summary
FieldDetail
CompanyHerbalife LTD. (HLF)
Form Type10-Q
Filed DateJul 31, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.0005
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, herbalife

TL;DR

Herbalife's Q2 10-Q is in. Check SG&A and prepaid expenses.

AI Summary

Herbalife Ltd. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position. Key financial data and disclosures are provided, including information on selling, general, and administrative expenses, as well as prepaid expenses and other current assets.

Why It Matters

This filing provides investors with an update on Herbalife's financial health and operational performance for the second quarter of 2024, influencing investment decisions.

Risk Assessment

Risk Level: medium — The filing contains standard financial disclosures for a public company, but the nature of Herbalife's business model can introduce inherent risks.

Key Numbers

Key Players & Entities

FAQ

What is the filing date for this 10-Q report?

The filing date for this 10-Q report is July 31, 2024.

What period does this 10-Q cover?

This 10-Q report covers the period ending June 30, 2024.

What is the Central Index Key (CIK) for Herbalife Ltd.?

The Central Index Key (CIK) for Herbalife Ltd. is 0001180262.

What is the Standard Industrial Classification (SIC) code for Herbalife Ltd.?

The Standard Industrial Classification (SIC) code for Herbalife Ltd. is 5122, which corresponds to Wholesale - Drugs, Proprietaries & Druggists' Sundries.

What are some of the financial statement line items referenced in the filing's header?

The filing's header references line items such as SellingGeneralAndAdministrativeExpense, PrepaidExpenseAndOtherAssetsCurrent, and OtherLiabilitiesCurrent.

Filing Stats: 4,425 words · 18 min read · ~15 pages · Grade level 9.8 · Accepted 2024-07-31 16:19:17

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Unaudited Condensed Consolidated Balance Sheets 3 Unaudited Condensed Consolidated Statements of Income 4 Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income 5 Unaudited Condensed Consolidated Statements of Cash Flows 6 Notes to Unaudited Condensed Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 36 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 56 Item 4.

Controls and Procedures

Controls and Procedures 59

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 62 Item 1A.

Risk Factors

Risk Factors 62 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 62 Item 3. Defaults Upon Senior Securities 62 Item 4. Mine Safety Disclosures 62 Item 5. Other Information 62 Item 6. Exhibits 62 2

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements HERBALIFE LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) June 30, 2024 December 31, 2023 (in millions, except share and par value amounts) ASSETS Current assets: Cash and cash equivalents $ 374.0 $ 575.2 Receivables, net of allowance for doubtful accounts 82.8 81.2 Inventories 480.7 505.2 Prepaid expenses and other current assets 276.3 237.7 Total current assets 1,213.8 1,399.3 Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 468.2 506.5 Operating lease right-of-use assets 188.3 185.8 Marketing-related intangibles and other intangible assets, net 313.1 314.0 Goodwill 91.5 95.4 Other assets 327.3 308.4 Total assets $ 2,602.2 $ 2,809.4 LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable $ 81.3 $ 84.0 Royalty overrides 316.5 343.4 Current portion of long-term debt 21.7 309.5 Other current liabilities 556.7 540.7 Total current liabilities 976.2 1,277.6 Long-term debt, net of current portion 2,321.0 2,252.9 Non-current operating lease liabilities 173.3 167.6 Other non-current liabilities 168.9 171.6 Total liabilities 3,639.4 3,869.7 Commitments and contingencies Shareholders' deficit: Common shares, $ 0.0005 par value; 2.0 billion shares authorized; 100.7 million (2024) and 99.2 million (2023) shares outstanding 0.1 0.1 Paid-in capital in excess of par value 253.4 233.9 Accumulated other comprehensive loss ( 257.4 ) ( 232.0 ) Accumulated deficit ( 1,033.3 ) ( 1,062.3 ) Total shareholders' deficit ( 1,037.2 ) ( 1,060.3 ) Total liabilities and shareholders' deficit $ 2,602.2 $ 2,809.4 See the accompanying notes to unaudited condensed consolidated financial statements. 3 HERBALIFE LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing